chr5-14488019-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007118.4(TRIO):​c.7391C>T​(p.Ala2464Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,593,756 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0069 ( 12 hom., cov: 32)
Exomes 𝑓: 0.00065 ( 12 hom. )

Consequence

TRIO
NM_007118.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.69

Publications

5 publications found
Variant links:
Genes affected
TRIO (HGNC:12303): (trio Rho guanine nucleotide exchange factor) This gene encodes a large protein that functions as a GDP to GTP exchange factor. This protein promotes the reorganization of the actin cytoskeleton, thereby playing a role in cell migration and growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
TRIO Gene-Disease associations (from GenCC):
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • intellectual developmental disorder, autosomal dominant 63, with macrocephaly
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics
  • micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002985239).
BP6
Variant 5-14488019-C-T is Benign according to our data. Variant chr5-14488019-C-T is described in ClinVar as Benign. ClinVar VariationId is 445920.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00694 (1056/152124) while in subpopulation AFR AF = 0.024 (998/41530). AF 95% confidence interval is 0.0228. There are 12 homozygotes in GnomAd4. There are 518 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1056 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIONM_007118.4 linkc.7391C>T p.Ala2464Val missense_variant Exon 48 of 57 ENST00000344204.9 NP_009049.2 O75962-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOENST00000344204.9 linkc.7391C>T p.Ala2464Val missense_variant Exon 48 of 57 1 NM_007118.4 ENSP00000339299.4 O75962-1

Frequencies

GnomAD3 genomes
AF:
0.00691
AC:
1050
AN:
152012
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0240
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00146
AC:
293
AN:
200460
AF XY:
0.000999
show subpopulations
Gnomad AFR exome
AF:
0.0237
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000480
Gnomad OTH exome
AF:
0.000397
GnomAD4 exome
AF:
0.000651
AC:
938
AN:
1441632
Hom.:
12
Cov.:
36
AF XY:
0.000549
AC XY:
393
AN XY:
715514
show subpopulations
African (AFR)
AF:
0.0238
AC:
780
AN:
32838
American (AMR)
AF:
0.00116
AC:
50
AN:
43060
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25660
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38432
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83288
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49908
Middle Eastern (MID)
AF:
0.000552
AC:
3
AN:
5434
European-Non Finnish (NFE)
AF:
0.0000190
AC:
21
AN:
1103548
Other (OTH)
AF:
0.00140
AC:
83
AN:
59464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
58
115
173
230
288
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00694
AC:
1056
AN:
152124
Hom.:
12
Cov.:
32
AF XY:
0.00696
AC XY:
518
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0240
AC:
998
AN:
41530
American (AMR)
AF:
0.00287
AC:
44
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5120
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67926
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
52
104
157
209
261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00244
Hom.:
5
Bravo
AF:
0.00773
ESP6500AA
AF:
0.0218
AC:
76
ESP6500EA
AF:
0.000136
AC:
1
ExAC
AF:
0.00177
AC:
204
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Oct 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 28, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.047
T;T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.61
T;T
MetaRNN
Benign
0.0030
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L;.
PhyloP100
1.7
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.46
N;.
REVEL
Benign
0.20
Sift
Benign
0.19
T;.
Sift4G
Benign
0.35
T;T
Polyphen
0.99
D;.
Vest4
0.10
MVP
0.51
MPC
0.43
ClinPred
0.0051
T
GERP RS
2.8
PromoterAI
-0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.033
gMVP
0.23
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115054458; hg19: chr5-14488128; COSMIC: COSV99080762; COSMIC: COSV99080762; API